Effectiveness of an anti-inflammatory drug, loxoprofen, for patients with nocturia

International Journal of Urology

Volumn 12, Issue 8, 2005, Pages 779-782

  Saito, Motoaki ^a   Kawatani, Masahito ^b   Kinoshita, Yukako ^a   Satoh, Keisuke ^a   Miyagawa, Ikuo ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

BPH (benign prostatic hyperplasia); Loxoprofen; Nocturia; NSAIDs; OAB (overactive bladder)

Indexed keywords

ANTIINFLAMMATORY AGENT; ETHYL LOFLAZEPATE; LOXOPROFEN; NAFTOPIDIL; PROPIVERINE; TAMSULOSIN; URAPIDIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FATIGUE; FEMALE; HUMAN; MALE; NIGHT SLEEP; NOCTURIA; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SINGLE DRUG DOSE; STOMACH DISEASE; TREATMENT OUTCOME; URINE VOLUME;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHENYLPROPIONATES; PROSTATIC HYPERPLASIA; TREATMENT OUTCOME; URINARY INCONTINENCE; URINATION DISORDERS;

EID: 28544437103     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2005.01138.x     Document Type: Article

References (11)

1. Resnick NM, Yalla SV. Geriatric incontinence and voiding dysfunction. In: Walsh PC, Retik AB, Vaughan ED Jr et al. (eds). Campbell's Urology, 8th edn. WB Saunders, Philadelphia, 2002; 1224-5.
2. Le Fanu J. The value of aspirin in controlling the symptoms of nocturnal polyuria. BJU Int. 2001; 88: 126-7.
3. Araki T, Yokoyama T, Kumon H. Effectiveness of a nonsteroidal anti-inflammatory drugs for nocturia on patients with benign prostatic hyperplasia: a prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleeping. Acta Med. Okayama 2004; 58: 45-9.
4. Herbert E, Jacson R, Fredin D et al. Evidences that separate PGE2 receptor modulate water and sodium transport rabbit cortical collecting duct. Am. J. Physiol. 1995; 265: F643-52.
5. Larsen GK. Indomethacin and symptomatic relief of benign prostatic hyperplasia. JAMA 1995; 273: 347.
6. Maggi A. Prostanoids as local modulator of reflex micturition. Pharmacol. Res. 1992; 25: 13-20.
7. Matsuda K, Tanaka Y, Ushiyama S et al. Inhibition of prostaglandin synthesis by sodium 2-[4-(2-oxocyclopentylmethyl) phenyl]propionate dihydrate (CS-600), a new anti-inflammatory drugs, and its active metabolite in vitro and in vivo. Biochem. Pharmacol. 1984; 33: 2473-8.
8. Sugimoto M, Kojima T, Asami M et al. Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-Na, an anti-inflammatory prodrug. Biochem. Pharmacol. 1991; 42: 2363-8.
9. van Kerrbroeck P, Abrams P, Chaikin D et al. The standardization of terminology in nocturia: report from the standardization sub-committee of the International Continence Society. Neurourol. Urodyn. 2002; 21: 179-83.
10. Al-Waili NS. Increased urinary nitrite excretion in primary enuresis. effects of indomethacin treatment on urinary and serum osmolaity and electrolytes, urinary Volumes and nitrite excretion. BJU Int. 2002; 90: 294-301.
11. Shinozaki S, Saito M, Kawatani M. Loxoprofen inhibits facilitated micturition reflex induced by acetic acid urinary bladder infusion of the rat. Biomed. Res. 2005; 26: 29-33.